内巴克洛芬对严重脊柱上性患者膀功能的影响
Markus Kofler1, Lucas-Michael Halbmayer1, Gusztav Kiss2
1Department of Neurology, Hochzirl Hospital, Zirl, Austria.
Neurourology and urodynamics
|January 16, 2025
概括
导管内巴克洛芬 (ITB) 改善了神经性膀患者的膀功能. 然而,一些患者可能会经历膀功能恶化,有脏损伤的风险,在治疗前没有明确的预测因素.
科学领域:
- 神经科学是一个神经科学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经性膀功能障碍源于神经疾病,如脊髓损伤或创伤性脑损伤 (TBI).
- 抑郁器过度活跃是中枢神经系统损伤的常见症状,导致膀非自愿收缩.
- 内巴克洛芬 (ITB) 主要用于性,但对神经性膀功能障碍有希望.
研究的目的:
- 评估内巴克洛芬 (ITB) 在改善严重脊上的患者的膀功能方面的疗效.
- 为了确定有关膀功能的ITB反应不良的潜在风险因素.
主要方法:
- 分析了接受ITB治疗的患有严重脊上的患者的泌尿动力学数据.
- 患者被分为良好的和不良的响应者,基于在稳定状态ITB剂量后的空余体积.
- 尿动力学研究是在ITB之前,手术后,以及有效稳定状态剂量进行的.
主要成果:
- ITB显著改善了膀容量,反射体积,并降低了排骨和膀压力.
- 良好和不良反应者在反应量,膀容量和稳定状态ITB的残留体积上有显著差异.
- 没有任何治疗前的泌尿动力学参数预测了对ITB的反应不佳.
结论:
- 在患有严重脊上的患者中,ITB对膀功能产生有益影响.
- 一部分患者可能会出现膀功能恶化,增加损伤的风险.
- 根据治疗前的泌尿动力学参数,预测ITB反应不佳的患者仍然是一个挑战.
相关概念视频
Drug Delivery: Parenteral Route
397
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
397
Local Anesthetics: Clinical Application as Spinal Anesthesia
576
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
576
Centrally Acting Muscle Relaxants: Therapeutic Uses
619
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
619
Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.2K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.2K


